Artificial Intelligence
A full-service platform for builders, businesses, and investors navigating the risks and rewards of AI

Goodwin’s Artificial Intelligence (AI) team advises clients, from early-stage startups and investors to global companies, that develop, provide, use, and invest in enterprise AI technologies. Our comprehensive legal platform was built to match the speed, scale, and complexity of AI innovation. As AI changes the world, we help our clients navigate the quickly shifting landscape from both a business and legal perspective.
Goodwin’s global AI team includes people with deep expertise on the real-world implications of AI, including those with advanced degrees in computer science and engineering. Our AI practice spans a variety of legal areas, such as intellectual property (IP), strategy and licensing, privacy, cybersecurity, financings and M&A, litigation, and regulatory compliance, across several industries, including technology, life sciences, healthcare, real estate, financial services, and private equity.
We advise hundreds of innovative companies and investors in the AI space, including those in cross-disciplinary sectors driving transformation such as proptech, digital health, and drug discovery. We also help guide clients that aren’t building or backing AI but want to understand how it’s affecting their business and learn how to use it to stay ahead of the curve. We actively contribute to the broader dialogue around AI, presenting at industry events and publishing regularly on the latest AI news.
Connect with our AI team and let us know how we can help.
Areas of Focus
Our AI Practice by Industry
AI raises different challenges in different industries. We help companies navigate those differences — from life sciences to healthcare and beyond.
AI in Life Sciences
We advise AI-native and AI-enabled life sciences companies on the legal, regulatory, and transactional decisions that shape growth across the full company life cycle.

AI in Healthcare
We help companies and investors navigate regulatory complexity, data risk, and commercialization in a rapidly evolving healthcare landscape.

Get in Touch
Connect with our AI team for guidance on navigating risk and opportunity.
Contacts
- Bethany P. Withers

Bethany P. Withers
PartnerCo-Chair AI - Kaitlin Betancourt

Kaitlin Betancourt
PartnerCo-Chair AI - Stephen G. Charkoudian

Stephen G. Charkoudian
Partner - Kevin V. Lam

Kevin V. Lam
Partner - Kevin LiuKL
Kevin Liu
Partner - Martin Gomez

Martin Gomez
Partner - Joel E. Lehrer

Joel E. Lehrer
Partner - Robert D. Carroll

Robert D. Carroll
Partner - Omer Tene

Omer Tene
Partner - Gretchen Scott

Gretchen Scott
Partner - L. Judson Welle

L. Judson Welle
Partner - Alexandra I. Russell

Alexandra I. Russell
Partner - Jennifer Merrigan Fay

Jennifer Merrigan Fay
Partner - Aaron Terwey

Aaron Terwey
Partner - Daniel Saposnik

Daniel Saposnik
Partner - William J. Schnoor Jr.

William J. Schnoor Jr.
Partner - Matthew Reardon

Matthew Reardon
Partner - Timothy Holahan

Timothy Holahan
Partner - Robert Frederickson III

Robert Frederickson III
Partner